We set out to identify genes that are commonly expressed in CD8+ T cells, killer immune cells that can drive anti-tumor immunity, across many types of human cancers.
Merck KGaA plans investment in new facility in Germany
Rendering of the new quality control building. Credit: © 2017 – 2024 Merck KGaA, Darmstadt, Germany and/or its affiliates. All rights reserved. German science and